Median annual list price for drugs approved by FDA in 2025 was $216,000 The FDA approved 51 new drugs in 2025, including five cell and gene therapies More than 67% of 2025 approvals were ...
In early 2025, the FDA was rocked by sweeping layoffs and leadership turnover, raising questions about whether the agency could maintain its pace in reviewing new drug applications. By the end of the ...
CDC provisional 12-month counts show overdose mortality peaked in 2022 after pandemic-era disruption and has declined annually since 2023, reaching pre-pandemic lows by end-2025. State heterogeneity ...
Illustration of New Drug Application paperwork surrounded by pills, vials, and DNA. The US Food and Drug Administration approved 46 new molecular entities in 2025. Credit: C&EN/Shutterstock The year ...
Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% ...
2025 drug approvals: Despite FDA tumult and macro uncertainty, biopharma scored with 55 new products
How did staff layoffs, inspection backlogs and unprecedented leadership turnover affect the ability of the FDA to approve new drugs in 2025? While it would be presumptuous to base conclusions solely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results